Financials Clariant AG

Equities

CLN

CH0012142631

Specialty Chemicals

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
13.26 ^CHF	+1.84%		+0.76%	+6.76%

Apr. 08	Citi recommends Wacker Chemie and Evonik - BASF, Lanxess 'Neutral'	DP
Apr. 03	Global markets live: Swiss Re, Intel, Walt Disney, Paramount, Microsoft...

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	7,121	6,198	6,262	4,822	4,086	4,361	-	-
Enterprise Value (EV) ¹	8,423	7,238	7,797	5,572	4,841	5,935	5,865	5,777
P/E ratio	720 x	8.22 x	18.3 x	56.3 x	30.3 x	18.4 x	14 x	11.9 x
Yield	16.4%	16.7%	2.11%	2.87%	3.38%	3.35%	3.74%	4.15%
Capitalization / Revenue	1.62 x	1.61 x	1.43 x	0.93 x	0.93 x	1.01 x	0.96 x	0.92 x
EV / Revenue	1.91 x	1.88 x	1.78 x	1.07 x	1.11 x	1.38 x	1.3 x	1.22 x
EV / EBITDA	11.4 x	11.7 x	10.3 x	6.24 x	7.55 x	8.46 x	7.41 x	6.68 x
EV / FCF	38.3 x	89.4 x	1,299 x	19 x	22.4 x	28.3 x	29.2 x	18.4 x
FCF Yield	2.61%	1.12%	0.08%	5.26%	4.46%	3.53%	3.43%	5.43%
Price to Book	2.84 x	2.76 x	2.65 x	2.06 x	2.03 x	2.1 x	1.93 x	1.76 x
Nbr of stocks (in thousands)	329,689	329,352	329,554	329,116	329,017	328,848	-	-
Reference price ²	21.60	18.82	19.00	14.65	12.42	13.26	13.26	13.26
Announcement Date	2/13/20	2/11/21	5/19/22	3/2/23	2/28/24	-	-	-

¹CHF in Million²CHF

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	4,399	3,860	4,372	5,198	4,377	4,311	4,526	4,750
EBITDA ¹	740	619	760	893	641	701.7	791.3	864.7
EBIT ¹	444	350	493	617	405	441	527.2	597.6
Operating Margin	10.09%	9.07%	11.28%	11.87%	9.25%	10.23%	11.65%	12.58%
Earnings before Tax (EBT) ¹	71	212	394	6	218	338.5	450.7	526.3
Net income ¹	10	758	344	84	134	241.7	317.4	376.1
Net margin	0.23%	19.64%	7.87%	1.62%	3.06%	5.61%	7.01%	7.92%
EPS ²	0.0300	2.290	1.040	0.2600	0.4100	0.7218	0.9478	1.117
Free Cash Flow ¹	220	81	6	293	216	209.7	201	313.7
FCF margin	5%	2.1%	0.14%	5.64%	4.93%	4.86%	4.44%	6.6%
FCF Conversion (EBITDA)	29.73%	13.09%	0.79%	32.81%	33.7%	29.88%	25.4%	36.27%
FCF Conversion (Net income)	2,200%	10.69%	1.74%	348.81%	161.19%	86.75%	63.33%	83.41%
Dividend per Share ²	3.550	3.150	0.4000	0.4200	0.4200	0.4443	0.4964	0.5502
Announcement Date	2/13/20	2/11/21	5/19/22	3/2/23	2/28/24	-	-	-

¹CHF in Million²CHF

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2019 S2	2020 S1	2020 S2	2021 S1	2021 Q3	2021 Q4	2021 S2	2022 Q1	2022 Q2	2022 S1	2022 Q3	2022 Q4	2022 S2	2023 Q1	2023 Q2	2023 S1	2023 Q3	2023 Q4	2023 S2	2024 Q1	2024 Q2	2024 S1	2024 Q3	2024 Q4	2024 S2	2025 Q1	2025 S1	2025 S2
Net sales ¹	2,170	1,945	1,915	2,034	1,096	1,242	2,338	1,262	1,301	2,563	1,312	1,323	2,635	1,200	1,084	2,284	1,031	1,062	-	1,043	1,031	2,042	1,101	1,181	2,204	-	2,187	2,167
EBITDA ¹	385	309	310	346	190	224	-	238	210	448	242	203	-	184	135	319	164	158	-	164	-	-	-	-	-	-	-	-
EBIT ¹	-	154	-	215	126	-	278	139	-	311	159	-	306	-	-	199	-	-	206	112	-	-	-	-	-	-	-	-
Operating Margin	-	7.92%	-	10.57%	11.5%	-	11.89%	11.01%	-	12.13%	12.12%	-	11.61%	-	-	8.71%	-	-	-	10.74%	-	-	-	-	-	-	-	-
Earnings before Tax (EBT)	164	-	-	-	-	-	-	-	-	-	-	-	-	-	-	190	-	-	-	-	-	-	-	-	-	-	-	-
Net income	121	75	683	93	101.5	101.5	-	184	184	369	-	-	-	-	-	209	-	-	-	-	93.25	-	-	206.8	-	-	-	-
Net margin	5.58%	3.86%	35.67%	4.57%	9.26%	8.17%	-	14.58%	14.14%	14.4%	-	-	-	-	-	9.15%	-	-	-	-	9.04%	-	-	17.51%	-	-	-	-
EPS	0.3700	-	-	-	0.3000	0.3000	-	0.5600	0.5600	1.120	-	-	-	-	-	0.6400	-	-	-	-	0.2833	-	-	0.6281	-	-	-	-
Dividend per Share ²	-	-	-	-	-	0.4000	-	-	-	-	-	0.4200	-	-	-	-	-	-	-	-	-	-	-	0.4410	-	-	-	-
Announcement Date	2/13/20	7/30/20	2/11/21	7/29/21	10/28/21	5/19/22	5/19/22	6/15/22	7/28/22	7/28/22	10/27/22	3/2/23	3/2/23	5/5/23	7/28/23	7/28/23	10/30/23	2/28/24	2/28/24	-	-	-	-	-	-	-	-	-

¹CHF in Million²CHF

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	1,302	1,040	1,535	750	755	1,574	1,505	1,417
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	1.759 x	1.68 x	2.02 x	0.8399 x	1.178 x	2.243 x	1.902 x	1.638 x
Free Cash Flow ¹	220	81	6	293	216	210	201	314
ROE (net income / shareholders' equity)	10.8%	9.01%	14.8%	3.58%	13.3%	12.7%	15.2%	14.9%
ROA (Net income/ Total Assets)	3.58%	2.87%	4.92%	1.27%	5.04%	4.16%	5.23%	5.47%
Assets ¹	279	26,409	6,985	6,614	2,657	5,812	6,073	6,880
Book Value Per Share ²	7.610	6.810	7.160	7.110	6.100	6.330	6.880	7.550
Cash Flow per Share ²	1.540	1.110	1.100	1.520	-	1.040	1.490	1.850
Capex ¹	289	288	357	209	207	223	236	248
Capex / Sales	6.57%	7.46%	8.17%	4.02%	4.73%	5.18%	5.22%	5.22%
Announcement Date	2/13/20	2/11/21	5/19/22	3/2/23	2/28/24	-	-	-

¹CHF in Million²CHF

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Clariant AG

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

13.26 CHF

Average target price

14.84 CHF

Spread / Average Target

+11.92%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
CLARIANT AG	+6.76%	4.77B
ECOLAB INC.	+11.47%	63.22B
SIKA AG	-3.47%	46.34B
GIVAUDAN SA	+13.72%	39.97B
FUJIFILM HOLDINGS CORPORATION	+17.83%	25.46B
EMS-CHEMIE HOLDING AG	+7.27%	18.68B
CELANESE CORPORATION	-0.57%	17.24B
POSCO FUTURE M CO., LTD.	-21.73%	15.81B
SYMRISE AG	+0.22%	14.9B
ALBEMARLE CORPORATION	-19.10%	13.74B

Other Specialty Chemicals